Mercy Medical Center - Baltimore, Maryland

Meet Our Doctors

Gynecologic Oncology Center at Mercy - Baltimore, MD
Hyung Ryu, M.D.

Hyung S. Ryu, M.D., is a highly skilled gynecologic surgeon, providing treatment of ovarian, cervical and uterine cancers at Mercy.

Specialty: Gynecologic Oncology

Spotlight On Mercy

Mercy Baltimore
Inpatient Access

Secure online access for Mercy inpatient stays and observations - view visit details, discharge instructions, medications and health information.


Inpatients sign up now >

    What's Happening at Mercy

    Mercy Medical Center in Baltimore, Maryland
    Mercy Ranked #2 Hospital in Maryland by U.S. News & World Report

    Mercy Medical Center has been ranked nationally in three adult medical specialties, named a high performer in six key adult specialties, and further recognized as the #2 hospital in the State of Maryland for 2014-15 by U.S. News & World Report

    Institute for Gynecologic Care at Mercy
    Everseat Means Faster Access to Care for Mercy Patients

    Mercy Medical Center has announced that it has entered into an agreement with Everseat to employ an all new mobile scheduling platform for its Women’s Services, including: Gynecology, Gynecologic Oncology, Breast Disease and Breast Cancer, Imaging Services such as mammograms, and Endocrinology, including diabetes, thyroid and bone health.

    Robotic Hysterectomy
    Dealing with Irregular Periods

    Irregular menstrual periods can leave women wondering if something is wrong, but it's often an issue that can be addressed, typically with medication.

    Mercy Women's Health Virtual Tour
    Mercy Named Among 100 Hospitals with “Great Women’s Health Programs”

    Becker's Hospital Review has published the 2014 edition of its annual list, "100 Hospitals with Great Women's Health Programs,” including Mercy Medical Center.

    Digestive Health and Liver Disease at Mercy - Dr. Jagganath
    Fecal Transplants for C. diff Infection

    The digestive disorder known as Clostridium difficile, or C. diff, is a potentially life-threatening intestinal infection, but there is an option out there that's fast and has about a 90-percent success rate.

    Institute for Digestive Health and Liver Disease at Mercy - Baltimore, MD
    Advances in Hepatitis C Treatment Provide Incentive for Screening

    The most common blood-borne viral infection in the United States, Hepatitis C (HCV), can lead to cirrhosis of the liver and liver cancer. It impacts more than 4 million people, the vast majority “baby boomers,” those born 1945-1965, who are encouraged to undergo a simple HCV blood test as significant breakthroughs have been made recently to successfully treat this disease.